Abstract
Background
Linalool is a monoterpenoid, also a vital silvichemical with commercial applications in cosmetics, flavoring ingredients, and medicines. Regulation of mevalonate (MVA) pathway metabolic flux is a common strategy to engineer Saccharomyces cerevisiae for efficient linalool production. However, metabolic regulation of the MVA pathway is complex and involves competition for central carbon metabolism, resulting in limited contents of target metabolites.
Results
In this study, first, a truncated linalool synthase (t26AaLS1) from Actinidia arguta was selected for the production of linalool in S. cerevisiae. To simplify the complexity of the metabolic regulation of the MVA pathway and increase the flux of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), we introduced the two-step isopentenyl utilization pathway (IUP) into S. cerevisiae, which could produce large amounts of IPP/DMAPP. Further, the S. cerevisiae IDI1 (ecoding isopentenyl diphosphate delta-isomerase) and ERG20F96W−N127W (encoding farnesyl diphosphate synthase) genes were integrated into the yeast genome, combined with the strategies of copy number variation of the t26AaLS1 and ERG20F96W−N127W genes to increase the metabolic flux of the downstream IPP, as well as optimization of isoprenol and prenol concentrations, resulting in a 4.8-fold increase in the linalool titer. Eventually, under the optimization of carbon sources and Mg2+ addition, a maximum linalool titer of 142.88 mg/L was obtained in the two-phase extractive shake flask fermentation.
Conclusions
The results show that the efficient synthesis of linalool in S. cerevisiae could be achieved through a two-step pathway, gene expression adjustment, and optimization of culture conditions. The study may provide a valuable reference for the other monoterpenoid production in S. cerevisiae.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12934-022-01934-x.
Keywords: Linalool, Saccharomyces cerevisiae, Metabolic engineering, Isopentenyl utilization pathway, Two-phase fermentation
Background
Terpenoids comprise the most abundant and diverse class of natural products with more than 80,000 identified compounds, widely used in medicine, flavors, biofuels and so on [1–3]. Many of those compounds have critical pharmacological properties in the treatment of cancer, malaria, inflammation, and a variety of infectious diseases [2], providing opportunities for the development of new drugs with low side effects. Linalool is an acyclic monoterpene alcohol that has a range of applications in perfumes and medicines due to its unique aroma and various biological activities such as sedative [4], antibacterial [5] and anticancer [6]. However, natural linalool, obtained mainly from spices such as camphor wood oil, is restricted by plant resources and insufficient to fulfill market demand. And synthetic linalool has poor enantioselectivity, health issues, and environmental pollution problems. Therefore, linalool synthesis in microbial platforms via fermentation has received extensive attention, which may provide a safe and sustainable alternative [7].So far, Saccharomyces cerevisiae, Yarrowia lipolytica, Escherichia coli, and Pantoea ananatis have been employed for the biosynthesis of linalool [8–11]. Nitta et al. expressed AaLINS from Actinidia arguta and the S80F mutant of farnesyl diphosphate synthase gene (IspAS80F) from E. coli combined with elevation of the precursor supply via the mevalonate pathway in P. ananatis, obtaining the highest ever reported linalool titer of 10.9 g/L in fed-batch fermentation [12]. S. cerevisiae is the attractive model organism and widely used for the commercial production of high-value chemicals due to its high safety, clear genetic background, and strong fermentation process stability [13].
Usually, the essential factors for the biosynthesis of linalool in microorganisms are linalool synthase and the immediate precursor geranyl pyrophosphate (GPP). GPP as a substrate for heterologous linalool synthase can synthesize enantioselective linalool [14]. In S. cerevisiae, GPP is synthesized from isopentenyl pyrophosphate (IPP) and dimethylallyl diphosphate (DMAPP) generated by the mevalonate (MVA) pathway with the catalysis of farnesyl diphosphate synthase (ERG20). However, ERG20 is a bifunctional enzyme that catalyzes the condensation of GPP and IPP into FPP, resulting in the inability to accumulate GPP. Meanwhile, FPP is an indispensable precursor in living organisms, so removing the FPP pool is not feasible. Therefore, enough GPP is one of the keys to improve linalool production. Several studies have shown that mutations at K197, F96, and N127 of ERG20 can prefer to produce GPP, especially double mutations of F96W and N127W (ERG20F96W−N127W) showed excellent ability to increase monoterpene production [15–17]. To date, several strategies have been established to increase the flux of GPP to linalool synthesis [8, 18–21]. A maximum linalool titer obtained in S. cerevisiae is 80.9 mg/L in shake-flask cultivation using a combinatorial modulation strategy that involved improving the expression level of linalool synthase by fusion a SKIK tag to N-terminus of t67OMcLISE343D/E352H, increasing the conversion efficiency of GPP to linalool by attaching RIDD and RIAD peptide tags with the C-terminus of ERG20F96W−N127W and SKIK-t67OMcLISE343D/E352H, and downregulation of native ERG20 to reduce sterol flux [20]. Nevertheless, compared with other monoterpenes such as limonene [22, 23], the linalool production by recombinant S. cerevisiae is still very low.
In S. cerevisiae, the MVA pathway requires seven steps, two nicotinamide adenine dinucleotide phosphate (NADPH) and three Adenosine triphosphate (ATP), involving a complex regulatory mechanism and competition for central carbon metabolism, which is responsible for product yields far below the theoretical maximum. Recently, the isopentenol utilization pathway (IUP), two-step synthesis of IPP and DMAPP using isoprenol or prenol as substrates, has been developed and can replace the MVA pathway for terpenoids biosynthesis [24–29]. For instance, engineering the linalool/nerolidol synthase (bLinS) of Streptomyces clavuligerus in combination with the IUP to construct recombinant E. coli resulted in an 800-fold increase in linalool production [30]. The advantage of the IUP is that it can bypass the complexity of the inherent pathway, consume minimal cofactors, and synthesize IPP in high throughput [24, 27]. In our previous work, the linalool synthase from Cinnamomum osmophloeum (CoLIS) and the F96W-N127W mutant of farnesyl pyrophosphate (ERG20F96W−N127W) were co-expressed respectively in the mitochondria that integrated the entire MVA pathway and in the cytoplasm that expressed the key enzymes tHMG1 and IDI1 as well as down-regulated endogenous ERG20, producing 23.45 mg/L linalool by fermentation [21]. However, the growth of engineered strains was severely affected due to the metabolic burden caused by overexpression of multiple genes [21]. Therefore, we speculated the IUP introduced into S. cerevisiae can simplify metabolic regulation and reduce the metabolic burden.
In the work, we sought to utilize the IUP to boost the production of linalool in S. cerevisiae (Fig. 1). First, different N-terminal truncated linalool synthases from Actinidia arguta were individually overexpressed in engineered S. cerevisiae to investigate the effect on linalool production in S. cerevisiae. Subsequently, the IUP was introduced into S. cerevisiae, and intracellular IPP and DMAPP contents were compared using the engineered MVA pathway and the IUP to determine the utility of IUP in S. cerevisiae. Further, three key enzyme genes involved in the linalool biosynthesis pathway were integrated into the S. cerevisiae genome and meanwhile optimized isoprenol and prenol to increase the linalool production. In addition, the effect of t26AaLS1 and ERG20F96W−N127W genes copy number on the linalool production was also examined. Finally, through the optimization of carbon source and Mg2+, the linalool production was increased to a high level in engineered S. cerevisiae.
Results and discussion
Comparison of two linalool synthases for linalool production in engineered S. cerevisiae
Generally, plant-derived linalool synthases exhibit low catalytic efficiency when heterologously expressed and are often considered the impediment to high linalool production. In a previous study, the performance of six (S)-specific linalool synthases from the plants was compared in Pantoea ananatis, and Actinidia arguta linalool synthase (AaLS1) showed the best (S)-linalool production with 100% enantio excess [31]. Therefore, to optimize heterologous linalool production in S. cerevisiae, the co-expression plasmid pYC-MAaLS1-MERG20F96W−N127W including AaLS1 and ERG20F96W−N127W with mitochondrial localization signal (MLS) sequence was transformed into strain BY4742-MC-02, generating strain YMC217. S. cerevisiae BY4742-MC-02 was reported in our previous work [21], which showed the strain with the whole MVA pathway in both mitochondria and cytoplasm and with a sufficient precursor supply. The strain YMC214 harboring the pYC-MLIS-MERG20F96W−N127W plasmid including (S)-linalool synthase gene from Cinnamomum osmophloeum was used as the experimental group and BY4742-MC-02 was used as the control. Since the parental strain BY4742-MC-02 has a GAL80 deletion, genes under the control of the GAL promoter also allows gene expression in the absence of galactose. Thus, GC-MS analysis was performed after the recombinant strains were cultured in SS-URA medium with 20% isopropyl myristate (IPM) for 72 h. As shown in Fig. 2, linalool was detected in YMC217, and the retention time was 11.37 min. Specifically, although both the strains YMC217 and YMC214 had little difference in the cell growth and sucrose consumption ability (Fig. 2D), the production of linalool by YMC217 overexpressing AaLS1 was determined to be 12.67 mg/L and showed 1.4-fold higher than that by YMC214 overexpressing CoLINS (9.22 mg/L). The results reflected that AaLS1 could at least equally or more effectively convert GPP to linalool than CoLINS used in our previous work [21].
Meanwhile, monoterpene synthases in plants have an N-terminal plastidic transit peptide, and the proper truncation site for monoterpene synthases can improve microbial monoterpene production [31]. The RR-heuristic motif is a conserved double arginine motif and residues upstream of the highly conserved RR motif are not required for monoterpene synthase activity [32]. And a previous study reported that deletion of residues upstream of the RR motif improved monoterpene synthase expression in yeast [31]. Thus, to improve the expression and activity of linalool synthase in S. cerevisiae, the N-terminal plastid targeting sequence truncation site of AaLS1 was predicted by the ChloroP or RR-heuristic method to obtain t26AaLS1 and t78AaLS1. The t26AaLS1 and t78AaLS1 fragments were obtained to construct pYC-Mt26AaLS1-MERG20F96W−N127W and pYC-Mt78AaLS1-MERG20F96W−N127W, respectively, which were transformed into strain BY4742-MC-02, generating the strains YMC218 and YMC219, respectively (Fig. 3A). The results showed that YMC218 carrying t26AaLS1 produced 23.81 mg/L of linalool, which was almost 1.9-fold higher than that of YMC217 carrying AaLS1 (Fig. 3B). Nevertheless, YMC219 carrying t78AaLS1 produced 5.29 mg/L of linalool and did not increase the production of linalool but harmed linalool synthesis (Fig. 3B), most likely due to improper N-terminal truncation position that impaired the activity of t78AaLS1. Similarly, the highest linalool titer and geraniol titer in S. cerevisiae from truncated Actinidia polygama LIS (t26ApLIS) and truncated Phyla dulcis geraniol synthase (t43PdGES), respectively, while the S. cerevisiae strains expressing t78ApLIS and t86PdGES produced less linalool and geraniol than ApLIS and PdLIS [31]. In addition, an aqueous-organic two-phase system to extract fermentation of terpenoids in recombinant S. cerevisiae is adopted as an effective strategy to reduce product toxicity and collect hydrophobic products [33, 34]. Isopropyl myristate (IPM) is a commonly used solvent in two-phase extractive fermentation and has been used to improve the production of terpenoids such as Alpha-Terpineol and linalool [17, 19, 20, 23]. A recent study showed that the use of isopropyl myristate as the extraction solvent in the ultrasonic-irradiated two-phase extractive fermentation significantly improved the carotenoid production of recombinant S. cerevisiae, and isopropyl myristate exhibited obvious advantages over dodecane and butyl oleate in the extraction of carotenoids [35]. To evaluate the effects of linalool production in two-phase extract fermentation using IPM, the above engineering strains in this study were cultured in SS-URA medium with and without IPM. When 20% IPM was added to the culture medium, the yield of linalool by YMC218 reached 23.94 mg/g DCW, representing a 103% increase compared with no overlay (11.81 mg/g DCW). As shown during linalool production, we confirmed that the medium covered with IPM can improve the production of linalool and hardly affect the growth of the strain. Furthermore, we also tested the effect of different concentrations of linalool added to the SS-URA medium on growth of the engineered S. cerevisiae strain. The results showed that the cell growth was significantly inhibited by more than 250 mg/L linalool (Additional file 1: Fig. S1).
Effects of introducing the IUP on synthesis of IPP/DMAPP in S. cerevisiae
Before constructing IUP in S. cerevisiae, we examined the tolerance of S. cerevisiae against isoprenol and/or prenol due to their toxicity to microbial hosts, affecting cell growth and target product yield [36, 37]. S. cerevisiae strain BY4742 was cultured in YPD medium supplemented with isoprenol and/or prenol at different concentrations. And optical density at 600 nm (OD600) was taken to evaluate the toxicity of isoprene and prenol in S. cerevisiae. After 24 h, the cell growth decreased by 55% and 73% for the addition of 100 mM isoprenol or prenol, respectively, compared with that without isoprenol or prenol (Additional file 1: Fig. S2A, B). With the addition of 200 mM isoprenol or prenol, cell growth was severely inhibited. A previous study has also shown that S. cerevisiae was more tolerant to isoprenol than E. coli, with a maximum half-inhibitory concentration of 7.79 g/L (~ 90 mM) to isoprenol, and S. cerevisiae showed no growth at 20 g/L isoprenol (~ 232 mM) [37]. When supplemented with 50 mM isoprenol and prenol, biomass decreased by 65%, and cell growth was dramatically affected (Additional file 1: Fig. S2C).
Although in our previous study, BY4742-MC-02 we constructed could increase the production of linalool through dual regulation of MVA pathways in the mitochondrial and cytoplasmic, the biomass was significantly reduced due to the excessive metabolic burden [21]. Several studies have demonstrated that the IUP can avoid complex regulation and central carbon metabolism, achieving efficient biosynthesis of terpenoids [24–29]. Therefore, to simplify the means of metabolic regulation and reduce the metabolic burden, we introduced IUP into S. cerevisiae. In order to use glucose or sucrose as a carbon source to regulate the expression of genes in the system, Sclin01 was obtained by knocking out the GAL80 gene on the BY4742 genome, which was the control group. It was reported that choline kinase from S. cerevisiae (ScCK) could convert isoprenol to appreciable amounts of both IP and DMAP and isopentenyl phosphate kinase from Arabidopsis thaliana (AtIPK) exhibited excellent performance in catalyzing the second step of IUP [24]. Thus, the AtIPK and ScCK genes encoding the IUP were cloned in the pUMRI-G plasmid, resulting in the plasmid pUMRI-G-AtIPK-ScCK. This plasmid was transformed into BY4742 so that the AtIPK and ScCK genes were inserted into the GAL80 locus in strain BY4742, generating strain Sclin02 (Fig. 4A). Subsequently, the intracellular IPP/DMAPP contents were analyzed by LC-MS/MS. As expected, a small amount of intracellular IPP/DMAPP was detected in Sclin01 using the native MVA pathway as a control, while the IUP-introduced strain Sclin02 significantly increased by 6.4-fold. And the biomass of Sclin02 decreased by 18.91% compared to Sclin01 (Fig. 4B). Importantly, IPP/DMAPP contents were not significantly different between Sclin02 and BY4742-MC-02, but the biomass of Sclin02 was 2.0-fold higher than that of BY4742-MC-02 (Fig. 4B). The effects of introducing IUP into S. cerevisiae on the synthesis of IPP and DMAPP in our study were consistent with that of introducing IUP into the peroxisome of Pichia pastoris (i.e., 7.8-fold) [38], but neither exhibited excellent performance as the introduction of IUP into the cytoplasm of Yarrowia lipolytica (i.e., 15.7-fold) [28]. The phenomenon may be related to the limited permeability of cells [38]. Overall, the results indicate that the IUP is an efficient strategy for the two-step synthesis of native MVA pathway products IPP/DMAPP in S. cerevisiae.
Enhancement linalool synthesis in S. cerevisiae using the IUP
To evaluate the utility of this strategy on linalool production in S. cerevisiae, t26AaLS1 and ERG20F96W−N127W were first introduced into Sclin02 by the plasmid pUMRI-H-t26AaLS1-ERG20F96W−N127W, generating the strain Sclin03. Meanwhile, previous studies have shown that it is an effective strategy to increase the synthesis of terpenoids by either adding an appropriate concentration of isoprenol [28] or controlling the ratio between isoprenol and prenol [26, 30]. Thus, Sclin03 was first tested for linalool production using various concentrations of isoprenol and/or prenol. After 96 h two-phase shake-flask culture, a maximum linalool titer of 23.44 mg/L supplied with 17.5 mM each of isoprenol and prenol was obtained. And linalool was also detected supplemented with other concentrations of isoprenol and prenol in combination (data not shown). However, no linalool was detected in cultures supplemented with only one of the two, probably due to isoprenol and prenol producing separately large amounts of IPP and DMAPP through the IUP pathway, resulting in excessive content of one of them not conducive to the formation of linalool.
IDI1 and ERG20 are the key enzyme genes in the linalool synthesis pathway, which play individually important roles in the interconversion and balance of IPP and DMAPP and the synthesis of GPP available, affecting the linalool production [39]. Thus, to investigate the effects of IDI1 and ERG20F96W−N127W on the production of linalool based on the IUP, two copies of IDI1, one copy of IDI1 and ERG20F96W−N127W were introduced into Sclin03, respectively, generating Sclin04 and Sclin05. As expected, the results showed that overexpression of either two copies of IDI1 or one copy of IDI1 together with ERG20F96W−N127W increased linalool production. Different contents of linalool were produced in Sclin04 when various concentrations of prenol were added to the medium (data not shown). However, with the addition of isoprenol to the medium, nerolidol significantly increased while linalool was not detected. We speculate that the conversion of IPP to DMAPP catalyzed by IDI1 enzyme is restricted, resulting in the unbalanced ratio of IPP and DMAPP, while the precursor GPP for linalool synthesis requires a 1:1 ratio of IPP to DMAPP, and when a lower intracellular level of DMAPP than IPP, IPP may still react with GPP to form other terpenoid precursors, such as FPP, resulting in a decrease in the metabolic flux of GPP to linalool. Notably, the highest titer of linalool in strain Sclin04 represented approximately 1.6-fold increases relative to Sclin03 at 17.5 mM each of isoprenol and prenol, reaching about 37.01 mg/L. To sum up, the results revealed that the combination of isoprenol and prenol had a significant effect on linalool production, which was similar to the results obtained in previous studies [25, 30].
When Sclin05 was tested using various concentrations of isoprenol and/or prenol, the results showed that the strain produced 8.55 mg/L linalool at 35 mM isoprenol, 17.28 mg/L at 35 mM prenol, and 53.03 mg/L at 17.5 mM each of isoprenol and prenol (Fig. 5). Specifically, the highest linalool titer in Sclin05 was almost 1.4-fold higher than that in Sclin04 under the same conditions, indicating that overexpression of IDI1 and ERG20F96W−N127W could better improve the production of linalool. The results illustrate that overexpression of IDI and ERG20 can enhance the downstream metabolic synthesis flux of IPP [28, 29]. In addition, in order to fully utilize IPP and DMAPP to convert into GPP, the geranyl pyrophosphate synthase gene from Abies grandis with the plastid-targeting sequence removed to generate tAgGPPS, which was inserted into strain Sclin03 together with IDI1. Unexpectedly, the resulting strain Sclin06 produced 24.65 mg/L of linalool, which decreased by 53% compared with Sclin05, although a previous study showed that overexpression of AgGPPS increased the production of geraniol in S. cerevisiae with ERG20K197E [40]. Herein, plant-derived GPP synthases introduced into S. cerevisiae to promote monoterpene synthesis requires further investigation.
Effect of increasing gene copy numbers on linalool production
The use of IUP to produce terpenoids may have to deal with the low utilization of IPP and DMAPP by downstream terpenoid synthesis [24]. Enhancing gene expression by regulating gene copy number is an effective approach to increasing metabolic pathway flux [29, 41]. For example, increasing the copy number of the related rate-limiting enzymes genes CrtE (encoding geranylgeranyl pyrophosphate synthase) and CrtI (encoding phytoene desaturase) in S. cerevisiae increased lycopene production from 118 mg/L to 186 mg/L [41]. As such, to further improve the production of linalool, 2, 3, 5, and 7 copies of t26AaLS1 and ERG20F96W−N127W were introduced into the genome of Sclin05, generating the strains Sclin05-2, Sclin05-3, Sclin05-5, and Sclin05-7, respectively, which required searching for suitable insertion sites on the genome. Genes LPP1 and DPP1 encode two phosphatases that accounted for most of the hydrolytic activities and deleting genes LPP1 and DPP1 could improve the production of terpenoids in yeast [42]. We first explored the effect of deleting LPP1 and DPP1 on cell growth and linalool production in strain Sclin05. The LPP1 and DPP1 genes were knocked out in Sclin05, generating single-knockout Sclin05-C2 (ΔLPP1) and double-knockout Sclin05-C3 (ΔLPP1, ΔDPP1), respectively. The results showed no visible effect on cell growth (Fig. 6A) and linalool production (data not shown) compared with Sclin05. Subsequently, t26AaLS1 was inserted together with ERG20F96W−N127W into the LPP1 or LPP1 and DPP1 sites in Sclin05 using the plasmids pUMRI-L-t26AaLS1-ERG20F96W−N127W and pUMRI-D-t26AaLS1-ERG20F96W−N127W, generating strain Sclin05-2 and Sclin05-3, respectively. As shown in Fig. 6B, the linalool titer of Sclin05-2 and Sclin05-3 was 79.48 mg/L and 94.39 mg/L, which were 49.9% and 78.0% higher than that of Sclin05, respectively. To investigate whether the genes t26AaLS1 and ERG20F96W−N127W were still the rate-limiting steps for Sclin05-3, we constructed Sclin05-5 and Sclin05-7 expressing 5 and 7 copies of t26AaLS1 together with ERG20F96W−N127W, respectively. The MLS1 gene, encoding cytosolic malate synthase, is involved in acetyl-CoA catabolism, and the deletion of the MLS1 gene can reduce the competition for acetyl-CoA with the MVA pathway and increase the production of terpenoids [23, 43]. And several studies have reported that deleting genes YPL062W, YJL064W, and ROX1 can improve the production of terpenoids in yeast [23, 29, 44, 45]. Thus, we further explored the effect of deleting genes MLS1, YPL062W, YJL064W, and ROX1 on cell growth and linalool production in Sclin05-C3. The above genes were knocked out in Sclin05-C3, generating double-knockout Sclin05-C5 (ΔMLS1, ΔYPL062W) and quadruple-knockout Sclin05-C7 (ΔMLS1, ΔYPL062W, ΔYJL064W, ΔROX1), respectively, resulting in a 37% increase in biomass (Fig. 6A) but no visible effect on linalool production (data not shown). Similarly, t26AaLS1 together with ERG20F96W−N127W were inserted into MLS1, YPL062W, YJL064W, and ROX1 sites in Sclin05-3, generating Sclin05-5 and Sclin05-7, respectively. Compared with the linalool titer in Sclin05-3, the titer of linalool was increased by 19.4% to 112.75 mg/L in Sclin05-5 and 20.8% to 114.08 mg/L in Sclin05-7, respectively (Fig. 6B). The results indicated that further integration of another two or four copies of t26AaLS1 together with ERG20F96W−N127W only led to a marginal increase in linalool production of the strains Sclin05-5 and Sclin05-7 when compared with Sclin05-3, and there was no significant change in linalool titer between Sclin05-5 and Sclin05-7. Moreover, compared to Sclin05-5, the biomass of Sclin05-7 decreased by 27%. Similarly, a previous study showed that adding one copy of CrtI increased lycopene production by 80.6% while introducing three copies of CrtI decreased both lycopene production and biomass [46]. The reason may be that excessive copy number increase imposes a metabolic burden on microbial growth [47]. Finally, the linalool production reached the maximum in the engineered strain Sclin05-5. The data suggested that increased downstream terpenoid metabolic flux is necessary when utilizing IUP to increase the heterologous synthesis of terpenoids.
Effects of carbon sources and Mg2+ addition in medium
Carbon sources can directly influence microbial growth and provide energy and carbon skeletons for the reproduction of microorganisms via a series of chemical reactions in vivo. In the strain Sclin05-5, the GAL regulation system was modified by GAL80 deletion, resulting in independence of gene expression on the absence of galactose. Depletion of glucose was able to induce the expression of PGAL-driven genes in this background [48, 49]. Therefore, glucose, galactose and sucrose were used individually as the carbon source of strain Sclin05-5 to explore the effect of carbon sources on the production of linalool. As shown in Fig. 7A, when galactose and sucrose were added to the medium separately to provide energy and carbon skeleton for the reproduction of microorganisms, the linalool yield reached 120.92 mg/L and 112.75 mg/L after being cultivated for 96 h, indicating that strain Sclin05-5 could utilize sucrose to produce linalool. And there was no significant difference in cell growth. The lowest linalool titer (43.58 ± 1.04 μg/L) was detected in YPD medium, although the cells grew better in YPD medium than in YPG and YPS.
Generally, Mg2+ plays a role in the process of growth and metabolism of living cells [50] and is related to the activity of monoterpene synthase [51, 52]. A previous study showed that adding Mg2+ to the medium increased the production of limonene by engineered Yarrowia lipolytica [52]. Herein, the effect of different concentrations of Mg2+ added to the medium on the linalool production by engineered S. cerevisiae was investigated. No significant changes were found in DCW under the experimental conditions, indicating that adding of Mg2+ had no visible effect on the growth of the engineered S. cerevisiae (Fig. 7B). With the addition of 10 mM Mg2+ to the medium, a maximum titer of linalool reached 142.88 mg/L, 27% higher than the control group (Fig. 7B). The results show that the optimized Mg2+ concentration can further improve the linalool titer.
Conclusion
In the present work, a S. cerevisiae platform was successfully developed as a high-linalool producer using IUP, a heterologously expressed linalool synthase, and an ERG20 mutation in S. cerevisiae to increase the linalool synthesis in S. cerevisiae. We first selected the truncated Actinidia arguta linalool synthase t26AaLS1, which improved linalool production when overexpressed in engineered S. cerevisiae strain with dual regulation of the MVA pathway in the mitochondria and cytoplasm, obtaining a linalool titer of 23.81 mg/L, a 2.6-fold increase compared to CoLIS. Further, by integrating t26AaLS1, ERG20F96W−N127W, and IDI into the yeast genome, the linalool titer in Sclin05 was 53.03 mg/L, a 2.3-fold increase compared to Sclin03, demonstrating the potential of utilizing the IUP pathway to increase linalool synthesis. Additionally, the strategy of copy number variation of the t26AaLS1 and ERG20F96W−N127W genes was employed to increase the metabolic flux of the downstream IPP, resulting in a significant increase in the linalool titer. Finally, strain Sclin05-5 was grown in YPS medium supplemented with 10 mM Mg2+, 17.5 mM isoprenol and prenol, and a maximum linalool titer reached 142.88 mg/L in a shake flask, which was the highest reported yet in engineered yeast strains, demonstrating the utility of these strategies for monoterpenes biosynthesis in yeast. Although we also tried to use plant-derived GPPS to improve the efficiency of converting IPP and DMAPP to GPP, the result was not as expected. Therefore, further research can focus on the supply of the precursor GPP. Besides that, placing the entire biosynthetic pathway that utilizes the IUP pathway to produce linalool in different cellular compartments of yeast may further increase linalool production [21, 29].
Methods
Strains and culture media
E. coli Trans1-T1 phage resistant chemically competent cell used for the construction of plasmids was cultivated in Luria–Bertani (LB) medium with 50 μg/mL kanamycin at 37 °C. S. cerevisiae BY4742 derived from S288c was used as the parent strain and cultured at 30 °C in YPD medium (1% yeast extract, 2% peptone, 2% glucose). YPG medium (1% yeast extract, 2% peptone, 2% galactose), and YPS medium (1% yeast extract, 2% peptone, 2% Sucrose) were used to cultivate recombinant S. cerevisiae strains. SS-URA medium (synthetic complete drop-out medium with 2% Sucrose and without uracil) was used to cultivate engineered S. cerevisiae strains containing episomal plasmids. Synthetic complete drop-out medium without a specific component (SD-URA or SD-LEU) was used for auxotroph selection of S. cerevisiae transformants.SD-FOA (1 mg/mL of 5-fluoroorotic acid in synthetic complete drop-out medium) was used for screening S. cerevisiae strains with KanMX-URA-PRB322ori marker excision [53].
Plasmids and strains construction
The relevant descriptions of the S. cerevisiae strains are summarized in Table 1. The corresponding plasmids and primers used in the study are listed in Additional file 1: Table S1 and S2, respectively. The pUMRI plasmids and the recombinant strains were constructed as described by Lv et al. [53]. The pUMRI-G, pUMRI-H, pUMRI-D, pUMRI-L, pUMRI-M, pUMRI-062, pUMRI-064 and pUMRI-R plasmids were constructed by replacing the Ty4 homologous arm in plasmid pUMRI-16 [54] with HO, DPP1, LPP1, MLS1, YPL062W, YJL064W and ROX1 homologous arms from S. cerevisiae BY4742, respectively. The HO homologous arms were amplified using primers HO-UP-F/HO-UP-R and HO-DN-F/HO-DN-R. The DPP1 homologous arms were amplified using primers DPP1-UP-F/DPP1-UP-R and DPP1-DN-F/DPP1-DN-R. The LPP1 homologous arms were amplified using primers LPP1-UP-F/LPP1-UP-R and LPP1-DN-F/LPP1-DN-R. The MLS1 homologous arms were amplified using primers MLS1-UP-F/MLS1-UP-R and MLS1-DN-F/MLS1-DN-R. The YPL062W homologous arms were amplified using primers 62-UP-F/62-UP-R and 62-DN-F/62-DN-R. The YJL064W homologous arms were amplified using primers 64-UP-F/64-UP-R and 64-DN-F/64-DN-R. The ROX1 homologous arms were amplified using primers ROX1-UP-F/ROX1-UP-R and ROX1-DN-F/ROX1-DN-R. The homologous arms above were individually introduced into pUMRI-16 linearized by primers pUMRI-F/pUMRI-R to generate the corresponding pUMRI vectors.
Table 1.
Name | Description | Source |
---|---|---|
Strains | ||
BY4742 | MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 | [55] |
BY4742-MC-02 | BY4742, ΔLPP1:TCYC1-ERG10-MLS-PGAL1-PGAL10-MLS- HMGS-TADH1; ΔHO: TTPS1-tHMG1-MLS-PGAL7-PGAL2-MLS-ERG12-TPGK1; | [21] |
ΔDPP1:TCYC1-tHMG1-MLS-PGAL1-PGAL10-MLS-PMK-TADH1; | ||
ΔGAL80:TTPS1-MVD1-MLS-PGAL7-PGAL2-MLS-IDI1-TPGK1 | ||
ΔPERG20-ERG20::PHXT1-ERG20-PTEF1-tHMG1 | ||
ΔTY4:PGAL1-IDI1-TCYC1 | ||
YMC214 | BY4742-MC-02, pYC-MLIS/MERG20F96W–N127W | [21] |
YMC217 | BY4742-MC-02, pYC-MAaLS1/MERG20F96W−N127W | This study |
YMC218 | BY4742-MC-02, pYC-Mt26AaLS1/MERG20F96W−N127W | This study |
YMC219 | BY4742-MC-02, pYC-Mt78AaLS1/MERG20F96W−N127W | This study |
Sclin01 | BY4742, ΔGAL80::LEU2 | This study |
Sclin02 | BY4742, ΔGAL80:: TCYC1-AtIPK-PGAL1-PGAL10-ScCK-TADH1 | This study |
Sclin03 | Sclin02, ΔHO::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1 | This study |
Sclin04 | Sclin03, ΔTy4::TCYC1-IDI1-PGAL1-PGAL10-IDI1-TADH1 | This study |
Sclin05 | Sclin03, ΔTy4::TCYC1-IDI1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1 | This study |
Sclin05-2 | Sclin05, ΔLPP1::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1 | This study |
Sclin05-3 | Sclin05-2, ΔDPP1::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1; | This study |
Sclin05-5 | Sclin05-3, ΔMLS1::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1; | This study |
ΔYPL062W::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1 | ||
Sclin05-7 | Sclin05-5, ΔYJL064W::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1; ΔROX1::TCYC1-t26AaLS1-PGAL1-PGAL10-ERG20F96W−N127W-TADH1 | This study |
Sclin05-C2 | Sclin05, ΔLPP1 | This study |
Sclin05-C3 | Sclin05-C2, ΔDPP1 | This study |
Sclin05-C5 | Sclin05-C3, ΔYPL062W, ΔMLS1 | This study |
Sclin05-C7 | Sclin05-C5, ΔYJL064W, ΔROX1 | This study |
The gene AaLS1 (GenBank ID: ADD81294) from Actinidia arguta, AtIPK (GenBank ID: AAN12957) from Arabidopsis thaliana, tAgGPPS (GenBank ID: AAN01134) from Abies grandis and ScCK (GenBank ID: AAA34499) from Saccharomyces cerevisiae were codon-optimized and synthesized by Sangon Biotech (Shanghai, China). The ERG20F96W−N127W, IDI1 gene, and LEU expression cassette were amplified from the plasmids constructed previously [21]. The N-terminal plastid targeting sequence truncation site of AaLS1 was predicted by the ChloroP or RR-heuristic method [31]. The full-length sequence of AaLS1 and the N-terminus truncated t26AaLS1 and t78AaLS1 were amplified using primers AaLS1-F/AaLS1-R, t26AaLS1-F/t26AaLS1-R and t78AaLS1-F/t78AaLS1-R, respectively. Then the genes mentioned above were cloned into the pYC-MLIS-MERG20F96W−N127W linearized by primers pYC-F/pYC-R to obtain pYC-MAaLS1-MERG20F96W−N127W, pYC-Mt26AaLS1-MERG20F96W−N127W and pYC-Mt78AaLS1-MERG20F96W−N127W, respectively. ERG20F96W−N127W and IDI1 genes were amplified using primers E20-F/E20-R and IDI1-F/IDI1-R, respectively. The purified t26AaLS1 and ERG20F96W−N127W fragments were introduced into pUMRI-H/D/L/M/062/064/R using BamH I/Sal I and EcoR I/Spe I, respectively, resulting in pUMRI-H/D/L/M/062/064/R-t26AaLS1-ERG20F96W−N127W. The purified IDI1 and ERG20F96W−N127W fragments were introduced into pUMRI-16-IDI1 using EcoR I/Spe I to construct plasmids pUMRI-16-IDI1-IDI1 and pUMRI-16-IDI1-ERG20F96W−N127W, respectively. The genes AtIPK and ScCK were amplified using primers AtIPK-F/AtIPK-R and ScCK-F/ScCK-R, respectively. The purified AtIPK and ScCK fragments were introduced into pUMRI-G using BamH I/Sal I and EcoR I/Spe I, respectively, resulting in plasmid pUMRI-G-AtIPK-ScCK. The GAL80UP-LEU-Gal80DN fragment was amplified using primers GAL80UP-F/GAL80UP-R, GAL80DN-F/GAL80DN-R, and LEU-F/LEU-R.
The plasmids or Sfi I-digested pUMRI plasmids were introduced into S. cerevisiae by electrotransformation performed with a Scientz-2C electroporation apparatus (Scientz Biotech, Ningbo, China). The GAL80UP-LEU-GAL80DN fragment was transformed into BY4742 and selected on SD-LEU plates to create strain Sclin01. To introduce the IUP into S. cerevisiae, the pUMRI-G-AtIPK-ScCK plasmid was transformed into BY4742 and selected on SD-URA plates to create strain Sclin02. The genes t26AaLS1 and ERG20F96W−N127W necessary for linalool production were integrated into the genome of Sclin02 using the recombinant pUMRI-H plasmid to obtain ScLin03. Similarly, the pUMRI-16-IDI1-IDI1 and pUMRI-16-IDI1-ERG20F96W−N127W plasmids were transformed into Sclin03 to create Sclin04 and Sclin05, respectively. The strains Sclin05-2/-3/-5/-7 were constructed using the same method above. Moreover, the recombinant pUMRI vectors were transformed into Sclin05 to create Sclin05-C2/C3/C5/C7. The genotypes of the recombinant strains were identified by PCR using primer pairs designed on the chromosomes and fragments at the integrated gene locations, respectively.
Cultivation in shaking flasks
A single colony of the recombinant yeast was inoculated into 5 mL of YPD medium for overnight growth at 30 °C, 200 rpm. Then the precultures were inoculated into 20 mL of YPD/YPG/YPS at an initial OD600 of 0.05. The optimal combination of 17.5 mM isoprenol and isoprenol (in DMSO) was added to the culture medium as substrates supply for IPP and DMAPP. 20% isopropyl myristate was added to the medium to reduce isoprenol and/or prenol volatilization and to extract linalool. Engineered S. cerevisiae strains containing episomal plasmids were cultured overnight in 5 mL SD-URA medium at 30 °C, 200 rpm. Then, the precultures were transfered into 20 mL of SS-URA medium with 20% isopropyl myristate (IPM) at an initial OD600 of 0.05, and cultured for 3–4 days.
Analytical method The dry cell weight (DCW) of S. cerevisiae was determined by harvesting 2 mL wet cell culture, washing twice with water, centrifugation at 12,000 rpm for 5 min, and then measuring the weight of cell pellet dried at 105 °C for 36 h.
The linalool from isopropyl myristate supernatants was centrifuged at 12,000 rpm for 5 min, diluted in hexane, and analyzed by gas chromatography-mass spectrometry (GC-MS, Agilent 6890 N GC coupled with 59,751 MSD) equipped with the DB-5 MS column (30 m × 0.25 mm, 0.25 μm film thickness, Agilent, USA). The sample (1 μL) with naphthalene as internal standard was injected in splitless mode. The temperature of the injector and mass spectrometer source was 240 °C and 230 °C, respectively. The carrier gas was helium at a flow rate of 1 mL/min. The oven temperature was held at 50 °C for 1 min, subsequently increased to 115 °C at a rate of 5 °C/min and further raised to 300 °C at the rate of 10 °C/min (hold for 5 min). The detailed detection method of intracellular IPP/DMAPP was described in the previous study [28].
Effects of isoprenol, prenol, and linalool on growth
The effects of isoprenol, prenol and linalool on the growth of S. cerevisiae strains were evaluated by measuring OD600. The frozen cells of strain BY4742 with 40 percent (vol/vol) glycerol were inoculated into YPD medium for overnight at 30 °C, 200 rpm. Then the cultures were transferred to YPS medium with different concentrations of isoprenol and/or prenol, and cultured for 24 h to make OD600 measurements. Similar operations were performed for the inhibitory effect of linalool on strain By4742-MC-02, recording the cell growth curve for 72 h.
Supplementary Information
Acknowledgements
We thank Professor Hongwei Yu (College of Chemical and Biological Engineering, Zhejiang University) for providing us with the plasmid pUMRI-16.
Author contributions
FT, YZ and XC conceived and designed the study. YZ and XC performed the experiments. YZ wrote the manuscript. JW and FT revised the manuscript. All authors contributed to the article and approved the submitted version. All authors read and approved the final manuscript.
Funding
This work was supported by the Basic Scientific Research Project of International Bamboo and Rattan Center (ICBR) of China (1632018007), the National 948 Project of China (2014-4-33) and the National Key Research and Development Program of China (Grant Number: 2016YFD0600801).
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its additional information file.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Yaoyao Zhang and Xianshuang Cao have contributed equally to this work
References
- 1.Christianson DW. Structural and chemical biology of terpenoid cyclases. Chem Rev. 2017;117:11570–11648. doi: 10.1021/acs.chemrev.7b00287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yang WQ, Chen X, Li YL, Guo SF, Wang Z, Yu XL. Advances in pharmacological activities of terpenoids. Nat Prod Commun. 2020;15:1–13. [Google Scholar]
- 3.Navale GR, Dharne MS, Shinde SS. Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 2021;105:457–475. doi: 10.1007/s00253-020-11040-w. [DOI] [PubMed] [Google Scholar]
- 4.Xu L, Li X, Zhang Y, Ding M, Zhao Y. The effects of linalool acupoint application therapy on sleep regulation. RSC Adv. 2021;11:5896–5902. doi: 10.1039/D0RA09751A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Silva CG, Yudice EDC, Campini PAL, Rosa DS. The performance evaluation of eugenol and linalool microencapsulated by PLA on their activities against pathogenic bacteria. Mater Today Chem. 2021;21:100493. doi: 10.1016/j.mtchem.2021.100493. [DOI] [Google Scholar]
- 6.Rodenak-Kladniew B, Castro MA, Crespo R, Galle M, de Bravo García M. Anti-cancer mechanisms of linalool and 1,8-cineole in non-small cell lung cancer A549 cells. Heliyon. 2020;6:e05639. doi: 10.1016/j.heliyon.2020.e05639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhu K, Kong J, Zhao B, Rong L, Liu S, Lu Z, Zhang C, Xiao D, Pushpanathan K, Foo JL, et al. Metabolic engineering of microbes for monoterpenoid production. Biotechnol Adv. 2021;53:107837. doi: 10.1016/j.biotechadv.2021.107837. [DOI] [PubMed] [Google Scholar]
- 8.Peng B, Nielsen LK, Kampranis SC, Vickers CE. Engineered protein degradation of farnesyl pyrophosphate synthase is an effective regulatory mechanism to increase monoterpene production in Saccharomyces cerevisiae. Metab Eng. 2018;47:83–93. doi: 10.1016/j.ymben.2018.02.005. [DOI] [PubMed] [Google Scholar]
- 9.Wu J, Wang X, Xiao L, Wang F, Li X. Synthetic protein scaffolds for improving R-(–)-linalool production in Escherichia coli. J Agric Food Chem. 2021;69:5663–5670. doi: 10.1021/acs.jafc.1c01101. [DOI] [PubMed] [Google Scholar]
- 10.Yh A, Mm A, Am A, Jik B, Nn A, Yn A, Yu A. Stereospecific linalool production utilizing two-phase cultivation system in Pantoea ananatis. J Biotechnol. 2020;324:21–27. doi: 10.1016/j.jbiotec.2020.09.021. [DOI] [PubMed] [Google Scholar]
- 11.Cao X, Wei LJ, Lin JY, Hua Q. Enhancing linalool production by engineering oleaginous yeast Yarrowia lipolytica. Bioresour Technol. 2017;245:1641–1644. doi: 10.1016/j.biortech.2017.06.105. [DOI] [PubMed] [Google Scholar]
- 12.Nitta N, Tajima Y, Yamamoto Y, Moriya M, Usuda Y. Fermentative production of enantiopure (S)-linalool using a metabolically engineered Pantoea ananatis. Microb Cell Fact. 2021 doi: 10.1186/s12934-021-01543-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Baptista SL, Costa CE, Cunha JT, Soares PO, Domingues L. Metabolic engineering of Saccharomyces cerevisiae for the production of top value chemicals from biorefinery carbohydrates. Biotechnol Adv. 2021;47:107697. doi: 10.1016/j.biotechadv.2021.107697. [DOI] [PubMed] [Google Scholar]
- 14.Herrero O, Ramón D, Orejas M. Engineering the Saccharomyces cerevisiae isoprenoid pathway for de novo production of aromatic monoterpenes in wine. Metab Eng. 2008;10:78–86. doi: 10.1016/j.ymben.2007.11.001. [DOI] [PubMed] [Google Scholar]
- 15.Camesasca L, Minteguiaga M, Fariña L, Salzman V, Aguilar PS, Gaggero C, Carrau F. Overproduction of isoprenoids by Saccharomyces cerevisiae in a synthetic grape juice medium in the absence of plant genes. Int J Food Microbiol. 2018 doi: 10.1016/j.ijfoodmicro.2018.05.025. [DOI] [PubMed] [Google Scholar]
- 16.Fischer MJC, Meyer S, Claudel P, Bergdoll M, Karst F. Metabolic engineering of monoterpene synthesis in yeast. Biotechnol Bioeng. 2011;108:1883–1892. doi: 10.1002/bit.23129. [DOI] [PubMed] [Google Scholar]
- 17.Zhang CB, Li M, Zhao GR, Lu WY. Alpha-Terpineol production from an engineered Saccharomyces cerevisiae cell factory. Microb Cell Fact. 2019;18:160. doi: 10.1186/s12934-019-1211-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yu D, Sun M, Sha X, Zhou J. Enhanced (S)-linalool production by fusion expression of farnesyl diphosphate synthase and linalool synthase in Saccharomyces cerevisiae. J Appl Microbiol. 2016;121:187–195. doi: 10.1111/jam.13105. [DOI] [PubMed] [Google Scholar]
- 19.Zhou PP, Du Y, Fang X, Xu NN, Yue CL, Ye LD. Improved linalool production in Saccharomyces cerevisiae by combining directed evolution of linalool synthase and overexpression of the complete mevalonate pathway. Biochem Eng J. 2020;161:107655. doi: 10.1016/j.bej.2020.107655. [DOI] [Google Scholar]
- 20.Zhou PP, Du Y, Fang X, Xu NN, Yue CL, Ye LD. Combinatorial modulation of linalool synthase and farnesyl diphosphate synthase for linalool overproduction in Saccharomyces cerevisiae. J Agric Food Chem. 2021;69:1003–1010. doi: 10.1021/acs.jafc.0c06384. [DOI] [PubMed] [Google Scholar]
- 21.Zhang YY, Wang J, Cao XS, Liu W, Yu HW, Ye LD. High-level production of linalool by engineered Saccharomyces cerevisiae harboring dual mevalonate pathways in mitochondria and cytoplasm. Enzyme Microb Technol. 2020;134:109462. doi: 10.1016/j.enzmictec.2019.109462. [DOI] [PubMed] [Google Scholar]
- 22.Ignea C, Raadam MH, Motawia MS, Makris AM, Vickers CE, Kampranis SC. Orthogonal monoterpenoid biosynthesis in yeast constructed on an isomeric substrate. Nat Commun. 2019;10:3799. doi: 10.1038/s41467-019-11290-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhang X, Liu X, Meng Y, Zhang L, Qiao J, Zhao G-R. Combinatorial engineering of Saccharomyces cerevisiae for improving limonene production. Biochem Eng J. 2021;176:108155. doi: 10.1016/j.bej.2021.108155. [DOI] [Google Scholar]
- 24.Chatzivasileiou AO, Ward V, Edgar SM, Stephanopoulos G. Two-step pathway for isoprenoid synthesis. Proc Natl Acad Sci U S A. 2019;116:506–511. doi: 10.1073/pnas.1812935116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lund S, Hall R, Williams GJ. An artificial pathway for isoprenoid biosynthesis decoupled from native hemiterpene metabolism. ACS Synth Biol. 2019;8:232–238. doi: 10.1021/acssynbio.8b00383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rico J, Duquesne K, Petit J-L, Mariage A, Darii E, Peruch F, de Berardinis V, Iacazio G. Exploring natural biodiversity to expand access to microbial terpene synthesis. Microb Cell Fact. 2019;18:23. doi: 10.1186/s12934-019-1074-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Clomburg JM, Qian S, Tan Z, Cheong S, Gonzalez R. The isoprenoid alcohol pathway, a synthetic route for isoprenoid biosynthesis. Proc Natl Acad Sci U S A. 2019;116:12810–12815. doi: 10.1073/pnas.1821004116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Luo Z, Liu N, Lazar Z, Chatzivasileiou A, Ward V, Chen J, Zhou J, Stephanopoulos G. Enhancing isoprenoid synthesis in Yarrowia lipolytica by expressing the isopentenol utilization pathway and modulating intracellular hydrophobicity. Metab Eng. 2020;61:344–351. doi: 10.1016/j.ymben.2020.07.010. [DOI] [PubMed] [Google Scholar]
- 29.Liu M, Lin YC, Guo JJ, Du MM, Wei DZ. High-level production of sesquiterpene patchoulol in Saccharomyces cerevisiae. ACS Synth Biol. 2021;10:158–172. doi: 10.1021/acssynbio.0c00521. [DOI] [PubMed] [Google Scholar]
- 30.Ferraz CA, Leferink NGH, Kosov I, Scrutton NS. Isopentenol utilization pathway for the production of linalool in Escherichia coli using an improved bacterial linalool/nerolidol synthase. ChemBioChem. 2021;22:2325–2334. doi: 10.1002/cbic.202100110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Denby CM, Li RA, Vu VT, Costello Z, Lin W, Chan LJG, Williams J, Donaldson B, Bamforth CW, Petzold CJ, et al. Industrial brewing yeast engineered for the production of primary flavor determinants in hopped beer. Nat Commun. 2018;9:965. doi: 10.1038/s41467-018-03293-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bohlmann J. Plant terpenoid synthases: molecular biology and phylogenetic analysis. Proc Natl Acad Sci U S A. 1998;95:4126–4133. doi: 10.1073/pnas.95.8.4126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Brennan T, Turner C, Krömer J, Nielsen L. Alleviating monoterpene toxicity using a two-phase extractive fermentation for the bioproduction of jet fuel mixtures in Saccharomyces cerevisiae. Biotechnol Bioeng. 2012;109:2513–2522. doi: 10.1002/bit.24536. [DOI] [PubMed] [Google Scholar]
- 34.Jiang GZ, Yao MD, Wang Y, Xiao WH, Yuan YJ. A “push–pull–restrain” strategy to improve citronellol production in Saccharomyces cerevisiae. Metab Eng. 2021;66:51–59. doi: 10.1016/j.ymben.2021.03.019. [DOI] [PubMed] [Google Scholar]
- 35.Yamada R, Ando Y, Mitsui R, Mizobata A, Yoshihara S, Tokumoto H, Matsumoto T, Ogino H. Improving carotenoid production in recombinant yeast, Saccharomyces cerevisiae, using ultrasound-irradiated two-phase extractive fermentation. Eng Life Sci. 2022;22:4–12. doi: 10.1002/elsc.202100051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Babel H, Krömer JO. Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol. Biotechnol Biofuels. 2020 doi: 10.1186/s13068-020-01825-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kim J, Baidoo EEK, Amer B, Mukhopadhyay A, Adams PD, Simmons BA, Lee TS. Engineering Saccharomyces cerevisiae for isoprenol production. Metab Eng. 2021;64:154–166. doi: 10.1016/j.ymben.2021.02.002. [DOI] [PubMed] [Google Scholar]
- 38.Liu H, Chen S-L, Xu J-Z, Zhang W-G. Dual regulation of cytoplasm and peroxisomes for improved a-farnesene production in recombinant Pichia pastoris. ACS Synth Biol. 2021;10:1563–1573. doi: 10.1021/acssynbio.1c00186. [DOI] [PubMed] [Google Scholar]
- 39.Liu YR, Ma XQ, Liang H, Stephanopoulos G, Zhou K. Monoterpenoid biosynthesis by engineered microbes. J Ind Microbiol Biotechnol. 2021 doi: 10.1093/jimb/kuab065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Campbell A, Bauchart P, Gold ND, Zhu Y, De Luca V, Martin VJJ. Engineering of a nepetalactol-producing platform strain of Saccharomyces cerevisiae for the production of plant seco-iridoids. Acs Synth Biol. 2016;5:405–414. doi: 10.1021/acssynbio.5b00289. [DOI] [PubMed] [Google Scholar]
- 41.Shi B, Ma T, Ye Z, Li X, Huang Y, Zhou Z, Ding Y, Deng Z, Liu T. Systematic metabolic engineering of Saccharomyces cerevisiae for lycopene overproduction. J Agric Food Chem. 2019;67:11148–11157. doi: 10.1021/acs.jafc.9b04519. [DOI] [PubMed] [Google Scholar]
- 42.Faulkner A, Chen X, Rush J, Horazdovsky B, Waechter CJ, Carman GM, Sternweis PC. The LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae. J Biol Chem. 1999;274:14831–14837. doi: 10.1074/jbc.274.21.14831. [DOI] [PubMed] [Google Scholar]
- 43.Chen Y, Siewers V, Nielsen J, Cobine P. Profiling of cytosolic and peroxisomal acetyl-CoA metabolism in Saccharomyces cerevisiae. PLoS ONE. 2012;7:e42475. doi: 10.1371/journal.pone.0042475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chen Y, Wang Y, Liu M, Qu J, Yuan Y. Primary and secondary metabolic effects of a key gene deletion ( ΔYPL062W ) on metabolically-engineered terpenoid-producing yeast. Appl Environ Microbiol. 2019 doi: 10.1128/AEM.01990-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hu T, Zhou J, Tong Y, Su P, Li X, Liu Y, Liu N, Wu X, Zhang Y, Wang J, et al. Engineering chimeric diterpene synthases and isoprenoid biosynthetic pathways enables high-level production of miltiradiene in yeast. Metab Eng. 2020;60:87–96. doi: 10.1016/j.ymben.2020.03.011. [DOI] [PubMed] [Google Scholar]
- 46.Xie WP, Lv XM, Ye LD, Zhou PP, Yu HW. Construction of lycopene-overproducing Saccharomyces cerevisiae by combining directed evolution and metabolic engineering. Metab Eng. 2015;30:69–78. doi: 10.1016/j.ymben.2015.04.009. [DOI] [PubMed] [Google Scholar]
- 47.Karim AS, Curran KA, Alper HS. Characterization of plasmid burden and copy number in Saccharomyces cerevisiae for optimization of metabolic engineering applications. FEMS Yeast Res. 2013;13:107–116. doi: 10.1111/1567-1364.12016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lv XM, Xie WP, Lu WQ, Guo F, Gu JL, Yu HW, Ye LD. Enhanced isoprene biosynthesis in Saccharomyces cerevisiae by engineering of the native acetyl-CoA and mevalonic acid pathways with a push–pull–restrain strategy. J Biotechnol. 2014;186:128–136. doi: 10.1016/j.jbiotec.2014.06.024. [DOI] [PubMed] [Google Scholar]
- 49.Wang F, Lv XM, Xie WP, Zhou PP, Zhu YQ, Yao Z, Yang CC, Yang XH, Ye LD, Yu HW. Combining Gal4p-mediated expression enhancement and directed evolution of isoprene synthase to improve isoprene production in Saccharomyces cerevisiae. Metab Eng. 2017;39:257–266. doi: 10.1016/j.ymben.2016.12.011. [DOI] [PubMed] [Google Scholar]
- 50.Austin S, Nowikovsky K. Mitochondrial osmoregulation in evolution, cation transport and metabolism. Biochim Biophys Acta Bioenerg. 2021;1862:148368. doi: 10.1016/j.bbabio.2021.148368. [DOI] [PubMed] [Google Scholar]
- 51.Chen XY, Yauk YK, Nieuwenhuizen NJ, Matich AJ, Wang MY, Perez RL, Atkinson RG, Beuning LL. Characterisation of an (S)-linalool synthase from kiwifruit (Actinidia arguta) that catalyses the first committed step in the production of floral lilac compounds. Funct Plant Biol. 2010;37:232–243. doi: 10.1071/FP09179. [DOI] [Google Scholar]
- 52.Pang Y, Zhao Y, Li S, Zhao Y, Li J, Hu Z, Zhang C, Xiao D, Yu A. Engineering the oleaginous yeast Yarrowia lipolytica to produce limonene from waste cooking oil. Biotechnol Biofuels. 2019;12:241. doi: 10.1186/s13068-019-1580-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lv XM, Wang F, Zhou PP, Ye LD, Xie WP, Xu HM, Yu HW. Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for improved isoprene production in Saccharomyces cerevisiae. Nat Commun. 2016;7:12851. doi: 10.1038/ncomms12851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Zhou PP, Xie WP, Li AP, Wang F, Yao Z, Bian Q, Zhu YQ, Yu HW, Ye LD. Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae. Enzyme Microb Technol. 2017;100:28–36. doi: 10.1016/j.enzmictec.2017.02.006. [DOI] [PubMed] [Google Scholar]
- 55.Baker Brachmann C, Davies A, Cost GJ, Caputo E, Li J, Hieter P, Boeke JD. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast. 1998;14:115–132. doi: 10.1002/(SICI)1097-0061(19980130)14:2<115::AID-YEA204>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this published article and its additional information file.